![](/img/cover-not-exists.png)
1674PSafety of belotecan as second-line treatment for recurrent small cell lung cancer: A phase IIb randomized multicenter study
Kang, J H, Kim, H T, Lee, K H, Kim, D-W, Kim, S-W, Kim, H R, Kim, J-H, Choi, J H, An, H J, Kim, J-S, Jang, J S, Kim, B-SVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy298.010
Date:
October, 2018
File:
PDF, 91 KB
2018